Lee Financial CO Novartis Ag Transaction History

Lee Financial CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$75.55 - $92.52 $45,330 - $55,512	-600 Reduced 66.67%	300 $27,000
Q2 2020 Aug 11, 2020	BUY	$80.93 - $91.1 $24,279 - $27,330	300 Added 50.0%	900 $79,000
Q3 2018 Nov 07, 2018	SELL	$66.94 - $77.43 $6,627 - $7,665	-99 Reduced 14.16%	600 $52,000
Q1 2018 May 09, 2018	BUY	$70.39 - $84.15 $6,968 - $8,330	99 Added 16.5%	699 $57,000
Q3 2017 Nov 07, 2017	BUY	$74.14 - $77.27 $44,484 - $46,362	600	600 $52,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.